Triveni Bio

Watertown, United States

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

$115.0M raised

Oct 2024

Series B

Top Investors

OrbiMedCormorant Asset ManagementPolaris PartnersFidelityViking Global Investors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Triveni Bio raised?

Triveni Bio has raised $115.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.

Who are Triveni Bio's investors?

Triveni Bio's investors include OrbiMed, Cormorant Asset Management, Polaris Partners, Fidelity, Viking Global Investors.

Where is Triveni Bio headquartered?

Triveni Bio is headquartered in Watertown, United States.

What does Triveni Bio do?

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

What stage is Triveni Bio at?

Triveni Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2024.

MLA

"Triveni Bio — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/triveni-bio. Accessed June 4, 2026.

APA

VCBacked. (2024). Triveni Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/triveni-bio

Wikipedia (cite web)

{{cite web |title=Triveni Bio — Funding & Investors |url=https://www.vcbacked.co/company/triveni-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2024.